Dr. Stephanie Bolle

Since July 2024, Stephanie Bolle is medical head at Protontherapy Center Quironsalud in Madrid, first proton therapy facility opened in Spain in 2019.

Her particular interest are brain and skull base tumours in children, adolescents and young adults.

She graduated in Medicine in 1998 at Liege University (Belgium) and obtained her Board Certificate in Radiation Oncology in 2003. From 2007, she worked in Radiation Oncology Department at Institut Curie in Paris until 2011 before to become referring radiation oncologist for paediatric patients at Gustave Roussy in Villejuif.

She have more of 15 years of experience in proton therapy.

She is currently member of the steering committee of SIOPe ROWG (Radiation Oncology working group) and active in SIOPe Brain tumour group as chair of radiotherapy subgroup and past co-chair of ependymoma subgroup.

Dr Stephanie Bolle is involved in international clinical trials as investigator in HARMONIC project (European-funded project aiming at better understanding the long-term effect of medical expose to ionising radiation in children treated with modern radiotherapy techniques) and co-investigator in BIOMEDE 2.0 study (personalized treatment in diffuse midline glioma). She is author of more than 100 articles (PubMed) and book chapters.

She was cited in the 100th best physicians in Spain by FORBES in 2025.

Radiation oncology at Liege University, Belgium (1998 — 2007)
Proton therapy specialist at Institut Curie in Paris, France (2007 — 2024)
Paediatric tumor specialist at Gustave Roussy Institute, France  (2011 — 2024)
Head of Radiation Oncology at Quironsalud Protontherapy Centre (since 2024)

Assessing late outcomes of advances in radiotherapy for paediatric cancers, HARMONIC-RT clinical trial
Diffuse glioma of medial line in children, BIOMEDE 2.0 clinical trial

Brain and skull base tumours in children, adolescents and young adult